Short answer
A negative RET family variant test is most reassuring when a known familial RET pathogenic variant was identified in an affected relative and the person tested negative for that exact variant. That is the classic true negative. A negative result is much less definitive when the family variant was never documented, when only tumor testing was done, or when the report wording does not match the family question.
What a true negative means
| Result wording | Common next question | Why it matters |
|---|---|---|
| Negative for known familial RET variant | Was the exact family variant tested? | This can be a true negative when the family result is documented. |
| No pathogenic RET variant detected | Was an affected relative tested first? | A broad negative may be uninformative if the family variant is unknown. |
| Tumor test negative | Was germline testing still indicated? | Tumor testing and inherited testing answer different questions. |
GeneReviews and the NCI MEN2 materials both emphasize that predictive testing is most useful when the familial pathogenic variant is already known. That is the point where a negative result can actually separate an at-risk relative from the inherited syndrome.
When a negative result is uninformative
- The family variant was never confirmed in an affected relative.
- The report says no pathogenic variant detected, but the tested person was not the best first person to test.
- Only tumor testing was performed, which does not replace germline testing for inherited risk.
- The family history still suggests MEN2, but the testing strategy was too limited to settle the question.
MedlinePlus and NCI both frame RET and MEN2 as inherited conditions where the test has to match the family question. If the test strategy is mismatched, a negative result can be technically accurate and still not clinically decisive.
Why the report wording matters
One of the biggest traps is assuming all negatives mean the same thing. A report that says negative for the known family variant is not the same as a broad no pathogenic variant detected. The first can be a true negative. The second may simply mean no variant was found in the assayed region or on the tested panel.
The exact wording also affects whether a child, sibling, or parent should still be offered targeted cascade testing.
What family members should do next
| Family situation | Practical next step | Why it matters |
|---|---|---|
| Known familial RET variant | Target the exact variant in at-risk relatives | That is the cleanest way to separate true negative from true positive. |
| No affected relative has been tested | Confirm the variant in the affected person first if possible | That creates a real comparison for cascade testing. |
| Child is at risk | Use genetics and pediatric endocrine follow-up | Some RET contexts can change childhood surveillance timing. |
NCI's childhood MEN2 guidance highlights why timing matters for children. The point of cascade testing is not just to label risk; it is to connect the result to surveillance and preventive care at the right age.
Questions to ask
- What exact RET variant was found in the family, and does this report name that same variant?
- Was the person tested the best first relative to test, or should the affected relative be confirmed first?
- Was the result from germline testing or only from tumor testing?
- Does this result change thyroid, adrenal, parathyroid, or childhood screening plans?
FAQ
When is a negative RET family variant result reassuring?
It is most reassuring when a known familial RET pathogenic variant was identified in an affected relative and the person tested negative for that exact variant.
When is a negative RET result uninformative?
It is less definitive when the family variant was never documented, when only tumor testing was done, or when the report wording does not match the family question.
Does a negative RET result rule out MEN2 risk?
No. It lowers the chance of a known familial RET cause, but the meaning depends on whether the test targeted the exact family variant and whether the clinical story still fits MEN2.
What should children do if the family RET variant is known?
Children at risk are usually offered targeted cascade testing with genetics and pediatric endocrine guidance so the result can guide timing of surveillance and family planning.
Why does the wording on the report matter?
Phrases like negative for known familial variant and no pathogenic variant detected can mean very different things. The exact wording helps determine whether the result is truly reassuring or simply incomplete for the family question.
What if the family variant was never confirmed in an affected relative?
That usually makes a negative result harder to interpret. In that setting, the next step is often to confirm the affected relative's result or revisit whether another affected family member should be tested first.
Related guides: MEN2 family variant testing, RET cascade testing for children questions, RET codon 609, 611, 618, and 620 questions, and positive RET test next steps.